Review
Copyright ©The Author(s) 2016.
World J Gastroenterol. Aug 21, 2016; 22(31): 6987-7005
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.6987
Figure 1
Figure 1 Candidate biomarkers in the mechanism of action and metabolism of the drugs in the Nab-paclitaxel/gemcitabine (A) and FOLFIRINOX (B) regimens.